ProQR Therapeutics NV (PRQR) stock is higher by 7.23% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives PRQR stock a score of 70 out of a possible 100.
That rank is influenced by a fundamental score of 90. In addition to the average rating from Wall Street analysts, PRQR stock has a mean target price of 20.666. This means analysts expect the stock to increase 223.92% over the next 12 months. PRQR's rank also includes a long-term technical score of 73. The short-term technical score for PRQR is 47.
What's Happening with PRQR Stock Today
ProQR Therapeutics NV (PRQR) stock has risen 12.28% while the S&P 500 is down -0.41% as of 9:59 AM on Thursday, Mar 25. PRQR is higher by $0.70 from the previous closing price of $5.68 on volume of 325,643 shares. Over the past year the S&P 500 has risen 56.45% while PRQR is higher by 7.23%. PRQR lost -$1.10 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on ProQR Therapeutics NV (PRQR) Stock.
